Evidence map›Paper›PMID 34466551›Full record

ArticleGalen medical journal2020

Value of Delta Fractional Flow Reserve (ΔFFR) For Predicting Coronary Ischemic Lesions.

Vahid Eslami, Morteza Safi, Mohammad Hasan Namazi, Mehdi Pishgahi, Amir Eftekharzade, Sayyed Ali Eftekharzadeh

Abstract read
In one paragraph

Article in Galen medical journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vahid EslamiShahid Beheshti University of Medical Sciences, Cardiovascular Research Center, Tehran, Iran.
Morteza SafiShahid Beheshti University of Medical Sciences, Cardiovascular Research Center, Tehran, Iran.
Mohammad Hasan NamaziShahid Beheshti University of Medical Sciences, Cardiovascular Research Center, Tehran, Iran.
Mehdi PishgahiShahid Beheshti University of Medical Sciences, Cardiovascular Research Center, Tehran, Iran.
Amir EftekharzadeShahid Beheshti University of Medical Sciences, Cardiovascular Research Center, Tehran, Iran.
Sayyed Ali EftekharzadehShahid Beheshti University of Medical Sciences, Cardiovascular Research Center, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe decrease in fractional flow reserve (FFR) after adenosine administration from baseline FFR value (termed as ΔFFR) may reflect the compensatory capacity of the microvascular circulation and thus may predict significant coronary stenotic lesions. We aimed to investigate whether baseline FFR and ΔFFR can help identify the coronary ischemic lesion and its severity. MATERIALS AND

methodsThis cross-sectional study was performed on 154 consecutive patients (Mean age 62.42 ± 9.36 years) that underwent coronary angiography and with definitive intermediate coronary lesions at any of the coronary vessels. FFR was calculated by dividing the mean distal intracoronary pressure by the mean arterial pressure. ΔFFR was also defined as the difference between baseline FFR and hyperemic FFR (considering FFR<0.75 as the criteria for ischemia).

resultsThe area under receiver-operating characteristic curve for baseline FFR was found as 0.933, and for ΔFFR was 0.946 indicated high values of both indices for predicting ischemic lesions. The best cut-off point for baseline FFR and ΔFFR for discriminating ischemic lesions from the normal condition was 89.5 (yielding a sensitivity of 92.2% and a specificity of 68.0%) and 9.5 (yielding a sensitivity of 96.0% and a specificity of 85.3%), respectively.

conclusionOur study could successfully demonstrate the high value of both baseline FFR and ΔFFR for predicting coronary ischemic lesions with the cut-off values of <89.5 and >9.5, respectively.

Indexed as

Coronary Artery DiseasesFractional Flow ReserveMyocardial InfarctionStenosis

Identifiers

PMID34466551
PMCPMC8344029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.